We are live on ! Find out more
Bronte Capital Management

Bronte Capital Management Portfolio holdings

AUM $931M Turnover 39.13%
1-Year Est. Return 47.97%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
–
AUM
$931M
AUM Growth
-$78.8M
Cap. Flow
-$108M
Cap. Flow %
-11.56%
Top 10 Hldgs %
71.82%
Holding
69
New
15
Increased
8
Reduced
33
Closed
12
Avg Time Held Equity + Options
1.9 years
Top 10 Avg Time Held Equity + Options
3.4 years
Top 20 Avg Time Held Equity + Options
2.8 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
3.4 years
Top 20 Avg Time Held Equity only
3.2 years

Sector Composition

Rank Sector Weight
1 Financials 23.01%
2 Miscellaneous 17.74%
3 Communication Services 15.44%
4 Healthcare 13.95%
5 Consumer Staples 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CHRS icon
51
Coherus Oncology
CHRS
$119M
$21.4K ﹤0.01%
15,262
-4,020
-21% -$6.56K
2025 Q4
2 quarters
MIST icon
52
Milestone Pharmaceuticals
MIST
$95M
$19.3K ﹤0.01%
14,390
+3,976
+38% +$6.36K
2025 Q4
2 quarters
GOSS icon
53
Gossamer Bio
GOSS
$59.8M
$11.2K ﹤0.01%
+847
New +$18.9K
2026 Q2
0 quarters
BF.A icon
54
CALL
Brown-Forman Class A
BF.A
$14.4B
– –
-493,902
Closed -$13.1M –
CRBU icon
55
Caribou Biosciences
CRBU
$48.5M
– –
-15,627
Closed -$29.7K –
IVVD icon
56
Invivyd
IVVD
$166M
– –
-11,012
Closed -$14.3K –
IWO icon
57
CALL
iShares Russell 2000 Growth ETF
IWO
$13.6B
– –
-4,400
Closed -$1.38M –
IWO icon
58
iShares Russell 2000 Growth ETF
IWO
$13.6B
– –
-37,542
Closed -$11.8M –
JRVR icon
59
James River Group Holdings
JRVR
$180M
– –
-338,961
Closed -$2.14M –
NKTR icon
60
CALL
Nektar Therapeutics
NKTR
$1.27B
– –
-202,500
Closed -$14.6M –
PINS icon
61
Pinterest
PINS
$10.9B
– –
-430,950
Closed -$7.9M –
PLRX icon
62
Pliant Therapeutics
PLRX
$50.1M
– –
-18,613
Closed -$23.5K –
RANI icon
63
Rani Therapeutics
RANI
$63.1M
– –
-14,868
Closed -$10.9K –
SBH icon
64
Sally Beauty Holdings
SBH
$1.71B
– –
-220,737
Closed -$3.06M –
GUTS icon
65
Fractyl Health
GUTS
$12.3M
– –
-1,409
Closed -$7.74K –

Similar funds

Bronte Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Bronte Capital Management held 69 positions worth $931M, down 7.8% from $1.01B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bronte Capital Management withdrew a net $108M in Q2 2026, closing 12 positions and reducing 33 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Bronte Capital Management opened a new position in Brown-Forman Class B worth $12.4M.

  • Bronte Capital Management's largest Q2 2026 buy was Brown-Forman Class B: 464,313 shares worth $12.4M.
  • Bronte Capital Management added most to Walt Disney in Q2 2026, an estimated $17.8M increase.
  • Bronte Capital Management's biggest Q2 2026 reduction was Interactive Brokers, cutting an estimated $33.1M.
  • Bronte Capital Management fully exited iShares Russell 2000 Growth ETF in Q2 2026, selling an estimated $11.8M.
  • Bronte Capital Management's ten largest holdings make up 72% of its $931M portfolio in Q2 2026.
  • Bronte Capital Management opened 15 new positions and closed 12 in Q2 2026.
  • Bronte Capital Management's portfolio value fell 7.8% quarter-over-quarter to $931M.

Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.